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This study presents a new multi-residue analytical method for the simultaneous 19 
determination of 38 psychoactive drugs (including benzodiazepines, antidepressants and 20 
drugs of abuse) and related metabolites in raw wastewater. Potential analyte losses 21 
during sample filtration and stability in wastewater were evaluated. Analyte losses, 22 
especially for 12 compounds, were observed during filtration, indicating a strong 23 
sorption onto the filter material. In order to overcome this effect, filtered water samples 24 
were combined with methanolic washes of the corresponding filters and the resulting 25 
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solutions were solid-phase extracted on mixed-mode (reverse-phase plus cation-26 
exchange) sorbents. Extracts were analyzed by ultra-high performance liquid 27 
chromatography-tandem mass spectrometry. Quantification was performed by the 28 
internal standard method with isotopic labeled analogs. Recovery percentages varied 29 
between 65% and 137%; method quantification limits ranged between 0.2 and 22 ng/L 30 
in ultrapure water and between 0.3 and 30 ng/L in wastewater for all the analytes but 31 
three (for which they were ~60-80 ng/L). The analysis of 24 h-composite samples 32 
collected during one week in the city of Santiago de Compostela demonstrated the 33 
ubiquity of 31 analytes, which were positively quantified in all samples. The highest 34 
concentrations were found for some of the antidepressants, with mean and maximum 35 
levels exceeding, in some cases, the levels previously reported in literature. This fact 36 
could be related to the additional washing step of the filters using methanol, which 37 
allowed to desorb retained analytes highlighting the importance of this step during the 38 
sample preparation protocol. 39 
 40 
Keywords: Benzodiazepines; Antidepressants; Substances of abuse; Sewage analysis; 41 
Solid-phase extraction; Ultra-High Performance Liquid Chromatography 42 
  43 
This is the author’s accepted manuscript of González-Mariño et al. J. Chromatogr. A, 1569 (2018) 91-100. © 2018. This 




1. Introduction 44 
Psychoactive pharmaceuticals, drugs of abuse and their metabolites are widely 45 
known to be present in urban wastewaters due to their high rates of production and 46 
consumption [1-9]. According to the Health Indicators of the Organization for 47 
Economic Co-operation and Development (OECD) [10], the use of antidepressants has 48 
increased considerably in most OECD countries since the year 2000, with selective 49 
serotonin reuptake inhibitors (SSRIs, e.g. fluoxetine, paroxetine, sertraline, citalopram) 50 
being the most popular in Spain [11]. Anxiolytics and hypnotics, particularly 51 
benzodiazepines (lorazepam, diazepam, alprazolam), are another group of medicines 52 
with remarkable rates of prescription [12]. And, among drugs of abuse, cannabis 53 
accounts for the largest estimate of abuse in the European Union, followed by cocaine, 54 
ecstasy, other amphetamine-derived compounds and opioids [13]. Following this 55 
widespread consumption, residues of licit and illicit psychoactive substances enter 56 
sewage systems continuously [1-9], a fact that may imply environmental consequences 57 
(if they end in surface waters [9, 14, 15]) and act as a measurable indicator of their use 58 
in different communities [2, 5, 16, 17]. 59 
Most of the analytical methodologies developed for the determination of 60 
psychoactive substances in wastewater remove suspended particles by filtration or 61 
centrifugation prior to solid-phase extracting the aqueous phase. However, organic 62 
molecules may get adsorbed onto solids following a process that depends on the 63 
properties of both the substance (pKa, Kow, etc.), the suspended particle matter (SPM) 64 
and the water itself (pH, Total Organic Carbon - TOC) and the filtering materials. 65 
Therefore, sorption is very hard to predict and, if a proper evaluation of the portion of 66 
substance adsorbed is not performed, it is possible to underestimate its levels in real 67 
samples [18-24]. In the case of drugs and pharmaceuticals, Baker et al. [18] assessed the 68 
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sorption onto wastewater SPM for 16 out of the 38 analytes included in our study and 69 
concluded that it was >10% for methadone and 2-ethylidene-1,5-dimethyl-3,3-70 
diphenylpyrrolidine (EDDP), and >30% (up to 89% in one of the samples) for some 71 
antidepressants like fluoxetine and norfluoxetine. This result highlighted the need to 72 
take sorption processes into consideration for the development of future sample 73 
preparation protocols for these analytes. 74 
In this line, this study presents a novel sample preparation strategy for the solid-75 
phase extraction (SPE) of 38 psychoactive drugs and metabolites in wastewater. 76 
Particular attention was paid to pretreatment steps, including water filtration, washing of 77 
the filters and in-sample stability, in order to avoid the under-reporting of 78 
concentrations in real wastewater. The analytes were carefully selected to be the most 79 
frequently prescribed psychoactive pharmaceuticals, the most frequently abused drugs 80 
in Spain and their most relevant metabolites: i) seven benzodiazepines and two of their 81 
metabolites; ii) methylphenidate - a psycho-stimulant drug used in the treatment of 82 
attention deficit hyperactivity disorder - and its main metabolite ritalinic acid; iii) eight 83 
antidepressants and five of their metabolites; and iv) eight illicit drugs, five metabolites 84 
and levamisole, the most common adulterant of cocaine. Analytes were separated and 85 
detected by ultra-high performance liquid chromatography (UHPLC) coupled to tandem 86 
mass spectrometry (MS/MS). Parameters affecting UHPLC separation and MS/MS 87 
detection were carefully optimized and the final method was validated in terms of 88 
trueness, precision and quantification limits. Finally, it was applied to the analysis of 24 89 
h-composite raw wastewater samples collected during one week in the city of Santiago 90 
de Compostela (NW of Spain).  91 
 92 
2. Experimental 93 
2.1. Reagents and materials 94 
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Analyte standards were supplied by Cerilliant (Round Rock, TX, USA) as 100 
individual solutions of 100 μg/mL of norsertraline and O-desmethylvenlafaxine, or 1000 101 
μg/mL in methanol (MeOH) of alprazolam, α-hydroxyalprazolam, diazepam, 102 
nordiazepam, oxazepam, temazepam, lorazepam, lormetazepam, chlordiazepoxide, 103 
methylphenidate, ritalinic acid, citalopram, N-desmethylcitalopram, fluoxetine, 104 
norfluoxetine, sertraline, venlafaxine, mirtazapine, N-desmethylmirtazapine, duloxetine, 105 
paroxetine, trazodone, amphetamine, methamphetamine, 3,4-106 
methylendioxymethamphetamine (MDMA), cocaine, benzoylecgonine, cocaethylene, 107 
levamisole, 11-hydroxy-Δ9-THC (THC-OH), 11-nor-9-carboxy-Δ9-THC (THC-108 
COOH), meta-chlorophenylpiperazine (mCPP), mephedrone, ketamine, methadone and 109 
EDDP. Isotopic labeled analogs (α-hydroxyalprazolam-D5, alprazolam-D5, diazepam-110 
D5, nordiazepam-D5, oxazepam-D5, temazepam-D5, lorazepam-D4, methylphenidate-111 
D9, ritalinic acid-D10, citalopram-D6, N-desmethylcitalopram-D3, fluoxetine-D6, 112 
norfluoxetine-D6, sertraline-D3, norsertraline-13C6, venlafaxine-D6, O-113 
desmethylvenlafaxine-D6, duloxetine-D3, paroxetine-D6, trazodone-D6, amphetamine-114 
D6, methamphetamine-D5, MDMA-D5, cocaine-D3, benzoylecgonine-D3, 115 
cocaethylene-D3, THC-OH-D3, THC-COOH-D3, mCPP-D8, mephedrone-D3, 116 
ketamine-D4, methadone-D3 and EDDP-D3) were also supplied by Cerilliant as 100 117 
μg/mL solutions in MeOH and used as internal standards (IS). Mixed stock solutions 118 
containing all the analytes (10 μg/mL) or all the IS (2 μg/mL) were prepared in MeOH 119 
and stored in the dark at -20°C until use. 120 
HPLC-grade MeOH, acetonitrile (ACN), acetic acid (100%) and ammonia 121 
solution in ultrapure water (25%) were supplied by Merck (Darmstadt, Germany). 122 
Formic acid (95-97%) and NH3 solution in MeOH (7M) were supplied by Sigma-123 
Aldrich (San Luis, Mi, USA). Ultrapure water was obtained in the laboratory by 124 
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purifying demineralized water in a Milli-Q Gradient A-10 system (Merck-Millipore, 125 
Bedford, MA, USA).  126 
 127 
2.2. Filtration tests  128 
Potential sorption of analytes onto different filter materials was assessed by 129 
vacuum filtering 100 mL aliquots of ultrapure water, spiked with 5 ng/mL of all the 130 
analytes, through different types of filters: 0.7 µm glass microfiber filters GF/A 131 
(Whatman, Kent, U.K.), 0.45 µm mixed cellulose membranes (Millipore, Bedford, MA, 132 
USA), 0.45 µm hydrophilic nylon membranes (Millipore) and 0.45 µm hydrophilic 133 
PVDF membranes (Millipore). IS were added after filtration and samples (n=3 in every 134 
case) solid-phase extracted as detailed in section 2.4. Losses were calculated as: 135 
𝐹𝑖𝑙𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑙𝑜𝑠𝑠 (%) =  (1 − (
𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒
𝐴𝑣𝑒𝑟𝑎𝑔𝑒(𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒𝑁𝑜 𝑓𝑖𝑙𝑡𝑟)
)) × 100 136 
Where 𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒 is the IS-corrected response in a filtered sample and 137 
𝐴𝑣𝑒𝑟𝑎𝑔𝑒(𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒𝑁𝑜 𝑓𝑖𝑙𝑡𝑟) is the average of the IS-corrected responses in non-filtered 138 
samples. One-way ANOVA (α=0.05) were performed to compare the mean losses of 139 
every analyte with the four types of filters. 140 
For the filters providing the best performance (GF), experiments were repeated 141 
with raw wastewater in order to assess the combined sorption onto the filter and the 142 
SPM. Aliquots (100 mL, n=3) were spiked with 5 ng/mL of all the analytes before and 143 
after being filtered,  IS added after filtration  and losses calculated as: 144 
𝐹𝑖𝑙𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑙𝑜𝑠𝑠 (%) =  (1 − (
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 (𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒𝐵𝑒𝑓𝑜𝑟𝑒)
𝐴𝑣𝑒𝑟𝑎𝑔𝑒(𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒𝐴𝑓𝑡𝑒𝑟)
)) × 100 145 
Where 𝐴𝑣𝑒𝑟𝑎𝑔𝑒(𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒
𝐵𝑒𝑓𝑜𝑟𝑒
) is the average of the IS-corrected responses in 146 
samples spiked before filtration; and 𝐴𝑣𝑒𝑟𝑎𝑔𝑒(𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒𝐴𝑓𝑡𝑒𝑟) is the average of the IS-147 
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corrected responses in samples spiked after filtration.  Individual Student’s t-tests 148 
(α=0.05) were run for all the analytes to assess whether there were statistically 149 
significant differences between their mean  filtration losses in ultrapure water versus in 150 
raw wastewater, i.e., whether there were differences between their sorption onto filters 151 
(exclusively) or their combined sorption onto filters and SPM.   152 
Finally, potential recovery of the analytes adsorbed by means of a methanolic 153 
wash of the filter was assessed with raw wastewater samples spiked with 2 ng/mL of all 154 
the analytes before and after filtration (n=3). Filters were washed with 2×5 mL of 155 
MeOH. Washes were collected, spiked with IS and made to a final volume of 1 mL for 156 
instrumental analysis.   157 
 158 
2.3. Antidepressant biodegradation tests  159 
Biodegradation of benzodiazepines and drugs of abuse was not assessed since it 160 
had been already reported in literature [25, 26]. 161 
Potential biodegradation of antidepressants was evaluated by spiking 10 mL of 162 
raw wastewater (n=3) with 500 ng/mL of these analytes and collecting 0.7 mL aliquots 163 
at the beginning of the experiment and at different times up to 48 h. Each aliquot was 164 
passed through a 0.22 µm GHP membrane syringe filter (Pall laboratory, NY, USA). 165 
Subsequently, 0.7 mL of MeOH were used to wash the filter and collected over the 166 
water fraction. The resulting solutions were spiked with 100 ng/mL of IS and kept at -167 
20°C until analysis (by direct injection into the UHPLC-MS/MS system). Signals were 168 
compared to the response of a standard in ultrapure water:MeOH 1:1 containing 250 169 
ng/mL and 100 ng/mL of analytes and IS, respectively.  170 
 171 
2.4. Sampling and sample treatment 172 
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Raw wastewater samples were collected at the wastewater treatment plant 173 
(WWTP) of Santiago de Compostela (NW of Spain), which treats mostly domestic 174 
wastewater and serves a population of ~136,500 inhabitants. Composite samples of 24 h 175 
were taken in April 2016 for seven consecutive days, from 10.00 a.m. to 10.00 a.m. of 176 
the following day. A Sigma SD900 portable sampler from Hach (Loveland, CO, USA) 177 
worked in time proportional mode collecting 120 mL of water every 10 min. Composite 178 
samples were transferred to the laboratory and extracted within 8 h after the end of the 179 
sampling.  180 
The sample preparation protocol was adapted from two previously published 181 
works [26, 27]. Under final working conditions, 100.0 mL aliquots were spiked with 20 182 
ng of IS and vacuum-filtered through 0.7 µm glass microfiber filters GF/A. Filters were 183 
washed with 2×5.0 mL of MeOH, which were collected together with the filtered 184 
aqueous sample. Resulting solutions were solid-phase extracted onto mixed reverse 185 
phase-cation exchange cartridges (Oasis MCX-150 mg, Waters Corp., Milford, MA, 186 
USA), previously conditioned with 5.0 mL of MeOH containing 5% of NH3 followed 187 
by 5.0 mL of ultrapure water. Sorbents were washed with 10.0 mL of ultrapure water 188 
and dried under nitrogen for 30 min. Analytes were recovered with 10.0 mL of 5% NH3 189 
in MeOH. Eluates were evaporated to dryness under nitrogen (99.999%) using both a 190 
Turbo-Vap II (Zymark, Hopkinton, MA USA) and a Mini-Vap concentrator (Sigma-191 
Aldrich). They were redissolved in 100 µL of MeOH for instrumental analysis. Every 192 
sample was processed in triplicate. 193 
 194 
2.5. UHPLC-MS/MS analysis 195 
Samples (2 µL) were injected into a Waters Acquity UPLC® H class system 196 
(Milford, MA, USA) equipped with a sample manager, a quaternary solvent pump and a 197 
This is the author’s accepted manuscript of González-Mariño et al. J. Chromatogr. A, 1569 (2018) 91-100. © 2018. This 




column oven. Chromatographic separation was carried out at 50°C on a Kinetex® EVO 198 
C18 100 Å column (50 × 2.1 mm I.D., particle size 1.7 μm) from Phenomenex 199 
(Torrance, CA, USA), protected with a C18 pre-column (4 × 2 mm I.D), also from 200 
Phenomenex. A dual eluent system consisting of (A) 5 mM of NH3 in ultrapure water 201 
and (B) 5 mM of NH3 in MeOH was employed at a flow rate of 0.5 mL/min. The 202 
gradient elution started with 30% B, increasing to 60% B in 4 min and then to 100% B 203 
in 0.01 min. 100% B was held for 2 min. Return to initial conditions (30% B) was 204 
performed in 0.01 min and held for 2 min for reconditioning. 205 
The UPLC® system was coupled to a triple quadrupole mass spectrometer Xevo 206 
TQD (Waters Corp., Milford, MA, USA) equipped with an electrospray ionization 207 
(ESI) source. Nitrogen, used as desolvation and cone gas, was provided by a nitrogen 208 
generator (Peak Scientific Spain, Barcelona, Spain). Argon, for the collision induced 209 
dissociation, was purchased from Praxair (Madrid, Spain). Ionization was performed in 210 
positive mode using the following parameters: 4 kV (capillary voltage), 150°C (source 211 
temperature), 500°C (desolvation temperature), 1000 L/h (desolvation gas flow, N2) and 212 
50 L/h (cone gas flow, N2). Collision energy (CE) and cone voltage (CV) values were 213 
adjusted individually for every compound. MS analyses were done in Selected Reaction 214 
Monitoring (SRM) mode recording one (IS) or two (analytes) precursor/product ion 215 
transitions per compound. Selected transitions, together with their corresponding CE 216 
and CV values, retention times (RT) and labeled compounds used as IS are listed in the 217 
Supplementary Material, Table S1. 218 
 219 
2.6. Method validation 220 
The method was validated in terms of linearity, instrumental repeatability, 221 
instrumental and method quantification limits (IQLs and MQLs), trueness and 222 
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precision. Analytes were quantified using the corresponding isotopic labeled analog as 223 
IS. In those (five) cases where no labeled analog was available, the labeled compound 224 
providing the best results in terms of trueness was selected (Table S1).  225 
Calibration was performed using a 13-point calibration curve ranging from 226 
individual IQLs to 1500 ng/mL. For sertraline, fluoxetine and lormetazepam, it ranged 227 
from IQL to 500 ng/mL; IS level in all cases: 200 ng/mL. IQLs were calculated as the 228 
concentration of a standard providing a signal-to-noise ratio (S/N) of 10. MQLs were 229 
assessed from measured concentrations in ultrapure water and wastewater samples 230 
containing (or spiked with) low concentrations of all the analytes, downscaling the 231 
levels for which the signal-to-noise ratio is 10. Instrumental repeatability was assessed 232 
as the relative standard deviation (%RSD) of six consecutive injections of two different 233 
standards (containing 5 and 50 ng/mL of all the analytes and 200 ng/mL of IS).  234 
Trueness and precision of the whole method were estimated from recovery experiments 235 
performed in ultrapure water spiked at two concentration levels (20 and 100 ng/L of all 236 
the analytes, 200 ng/L of all IS) and in raw wastewater spiked with 500 ng/L of all the 237 
analytes and 200 ng/L of all IS. In the latter case, IS only-spiked aliquots were analyzed 238 
simultaneously in order to correct for the levels of analytes in sewage. Responses 239 
(analyte area/IS area) in ultrapure water or differences between responses of analyte-240 
spiked and non-spiked aliquots of wastewater were compared with calibration curves in 241 
MeOH. 242 
 243 
3. Results and discussion 244 
3.1. UHPLC-MS/MS optimization 245 
MS/MS conditions (transitions, CE and CV values) were optimized by direct 246 
infusion of individual standard solutions (10 µg/mL) in MeOH. Ionization was 247 
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performed in positive mode. Two SRM transitions (one quantifier, one qualifier) were 248 
acquired per analyte and one transition per IS. CV and CE values providing the highest 249 
intensities were selected individually (Table S1).  250 
Chromatographic separation was carried out on a Kinetex® EVO C18 column stable 251 
throughout the whole pH range (1-12). Several modifiers giving different pH values 252 
were considered for the mobile phase (consisting of ultrapure water – mobile phase A, 253 
and MeOH – mobile phase B): formic acid 0.1% (pH 2.7); ammonium acetate 5 mM 254 
(pH 7.0); and NH3 5 mM (pH 10.5). Figure 1 displays the chromatograms of nine 255 
analytes representative of the different behaviours observed in the three different 256 
scenarios. Since most substances have basic groups, a basic pH ensures their 257 
neutralization, increasing their retention on the C18 phase and improving peaks shape. 258 
As an example, amphetamine derivatives split in two in acidic medium, so formic acid 259 
was discarded for them. This splitting was also observed for other basic compounds 260 
such as mephedrone, ketamine or methylphenidate, whose height was between 1.5 and 3 261 
times higher with NH3 than with ammonium acetate. Higher peaks were also obtained 262 
in basic medium for other basic, less polar species (e.g. duloxetine, sertraline) and for 263 
amphoteric compounds (e.g. benzoylecgonine, ritalinic acid), what demonstrates the 264 
higher sensitivity of the proposed method when a basic eluent system was used. On the 265 
contrary, THC-COOH and THC-OH peaks were higher with formic acid but, since this 266 
was a minor behaviour, NH3 was added at a concentration of 5 mM to both the aqueous 267 
and the organic phase. The use of MeOH or ACN was also considered, but no 268 
significant differences were observed neither on peak shapes nor on analyte intensities 269 
(data not shown), so MeOH was selected due to its lower price.  270 
The consecutive injection of 1, 2, 3, 4 and 5 µL of a standard showed that the 271 
greater the volume injected, the higher the intensity. As it is shown in Figure S1 of the 272 
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Supplementary Material, a reasonable peak width was maintained in all cases (e.g. 273 
trazodone) excepting ritalinic acid and benzoylecgonine, for which peaks were split. 274 
Although a certain percentage of water in the solvent used to prepare standards and 275 
reconstitute extracts could have avoided the split, it was discarded due to the already 276 
known poor stability of some of the investigated species in water (e.g. cocaine [28]). 277 
Alternatively, a compromise injection volume of 2 µL, which provided high signal 278 
intensity avoiding significant peak widening for benzoylecgonine and ritalinic acid, was 279 
adopted. As an example of the chromatographic performance, Figure 2 shows the 280 
extracted ion chromatogram (EIC) for the first transition of all the analytes in a 100 281 
ng/mL standard.   282 
 283 
3.2. Assessment of losses during sample filtration 284 
In first instance, sorption of analytes onto filters (exclusively) was assessed by 285 
comparing different filter materials: GF, cellulose membranes, hydrophilic nylon and 286 
hydrophilic PVDF (see section 2.2). Losses were lower than 30%, independently of the 287 
material used, for all analytes but methadone, its metabolite EDDP, the two 288 
cannabinoids and most of the antidepressants (Figure 3). An ANOVA statistical test 289 
allowed to conclude that differences between mean losses observed with the four types 290 
of filters were statistically significant, at the 95% of confidence level, for thirteen 291 
compounds: citalopram, N-desmethylcitalopram, fluoxetine, norfluoxetine, sertraline, 292 
mirtazapine, duloxetine, paroxetine, trazodone, THC-OH, THC-COOH, methadone and 293 
EDDP. For ten of them, higher losses were observed with cellulose membranes 294 
followed by PVDF filters. For mirtazapine and EDDP, there was barely no difference 295 
between these two materials. Conversely, lower adsorption occurred on GF and 296 
hydrophilic nylon, which were regarded as the best filtering materials. However, THC-297 
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OH and THC-COOH disappeared completely after being filtered through nylon, what 298 
prevented the selection of this material in favour of the use of GF. 299 
Combined sorption onto both SPM and GF filters was further assessed with raw 300 
wastewater and compared to the (exclusive) sorption on GF filters occurring with 301 
ultrapure water (Figure 4). At the 95% of confidence level, there were no statistically 302 
significant differences between the mean losses observed in these two matrices, 303 
indicating a strong sorption onto the filter material barely affected by the content of 304 
SPM. Only O-desmethylvenlafaxine, mirtazapine and EDDP underwent a significantly 305 
higher loss in ultrapure water. This may be attributed to the fact that dissolved organic 306 
matter partially prevents sorption to the filter unit.  307 
Desorption of analytes from filters by washing them with 2×10 mL of MeOH was 308 
evaluated with raw wastewater samples as explained in section 2.2. For most of the 309 
compounds, recoveries in the water extract were above 80% (data not shown), 310 
demonstrating again that sorption has not a great impact on them. For citalopram, N-311 
desmethylcitalopram, methadone and EDDP, recoveries varied between 60% and 80%, 312 
and for some compounds with high Kow (i.e. fluoxetine, norfluoxetine, sertraline, 313 
norsertraline, duloxetine, paroxetine, THC-OH and THC-COOH) they were below 50% 314 
(Supplementary Material, Figure S2).  For these analytes, recoveries in filter washes 315 
reached values above 20% of the total addition in the water sample. For citalopram, N-316 
desmethylcitalopram, methadone and EDDP they varied between 9 and 24% (Figure 317 
S2). For the remaining compounds, filter washes recoveries were below 10% in all 318 
cases.   319 
Therefore, the combination of the filtered water sample and the methanolic filter 320 
washes was further extracted and analysed, as explained in sections 2.4 and 2.5, in order 321 
to improve the accuracy and the sensitivity of the method. Moreover, the addition of IS 322 
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before filtration allowed us to compensate for the uncertainty associated to the sorption 323 
occurring during filtration, and also to avoid a potential underestimation of the 324 
concentrations found in wastewater.  325 
 326 
3.3. Stability of antidepressants in wastewater 327 
Stability experiments were performed as explained in section 2.3 for 328 
antidepressants and their metabolites. After sample filtration, recovery experiments 329 
showed that 0.7 mL MeOH were necessary to sweep the analytes from the filter, 330 
especially fluoxetine, norfluoxetine, sertraline, norsertraline, duloxetine and paroxetine. 331 
A second MeOH wash was not necessary, since less than 5% of the analytes were eluted 332 
in this fraction (data not shown). Figure S3 of the Supplementary Material compiles the 333 
biodegradation profiles for all the antidepressants along 48 h at room temperature. Since 334 
no significant degradation was observed in any case (relative responses >80%), no 335 
degradation is expected during the 24 h sampling. 336 
 337 
3.4. Method performance 338 
UHPLC-MS/MS performance parameters (linearity, instrumental repeatability 339 
and IQLs) are displayed in Table 1. The representation of the ratio analyte area/IS area 340 
versus analyte concentration fitted a linear model with determination coefficients (R2) 341 
between 0.9928 and 0.9987. The linear range was IQL-1500 ng/mL for all the analytes 342 
but sertraline, fluoxetine and lormetazepam, for which it was IQL-500 ng/mL. %RSD 343 
values for six repeated injections of a standard varied between 0.6 and 6.9% at 5 ng/mL 344 
and between 1.4 and 13% at 50 ng/mL. IQLs were between 0.1 and 13 ng/mL. 345 
The combined SPE-UHPLC-MS/MS method was validated in terms of trueness, 346 
precision and MQLs. Percentages of recovery (%R) for quatriplicate analyses of 347 
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ultrapure water samples spiked with 20 ng/L of all the analytes and 200 ng/L of IS 348 
varied between 71% for lormetazepam and 132% for norsertraline (Table 1). THC-349 
COOH could not be recovered in this case since its MQL in ultrapure water was higher 350 
than the spiked level (22 ng/L). %RSD were between 1% and 10%. At 100 ng/L in 351 
ultrapure water, %R varied from 72% for N-desmethylmirtazapine to137% for mCPP 352 
.%RSD were between 3% and 27%. In raw wastewater experiments (spiking level: 500 353 
ng/L of all the analytes, 200 ng/L of IS), %R varied from 65% for duloxetine to 134% 354 
for N-desmethylmirtazapine, with %RSD between 1% and 14%. Finally, MQLs ranged 355 
from 0.2 ng/L to 22 ng/L in ultrapure water and from 0.3 ng/L to 30 ng/L in wastewater 356 
for all the analytes but mCPP (82 ng/L), amphetamine (64 ng/L) and mephedrone (83 357 
ng/L).  358 
Table S2 offers a comparative of the performance of the proposed method versus 359 
other multi-residue analytical methods for the determination of psychoactive substances 360 
in wastewater. MQLs were in the same order of magnitude than MQLs reached by other 361 
methodologies [4, 6, 7, 26, 29-31]. Trueness was similar or even better, with IS 362 
corrected %R in the 65-134% range versus 39-226% [29], 32-125% [30] or 51-130% 363 
[4]. It must be noticed, however, that both MQL and %R values can be estimated in 364 
different ways and, therefore, performance figures offered by different researchers 365 
might not be readily comparable. In terms of analysis time, the optimized SPE protocol 366 
is as long as other off-line SPE protocols, being, of course, slower than the in-line SPE-367 
LC-MS/MS method developed by Fedorova et al. [31], or the Auto-SPE on HLB discs 368 
optimized by Baz-Lomba et al. [30]. The chromatographic separation is, conversely, the 369 
fastest (8 min in total).  370 
 371 
3.5. Occurrence in 24 h-composite wastewater samples 372 
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The optimized and validated method was used to analyze 24 h-composite raw 373 
wastewater samples collected during one week in April 2016 at the WWTP of Santiago 374 
de Compostela (Spain).  375 
Out of the 38 analytes, 31 could be positively quantified in all samples and two 376 
(α-hydroxyalprazolam and EDDP) in five and four samples, respectively (Table 2). 377 
Amphetamine, methamphetamine, mCPP, mephedrone and ketamine were always 378 
<MDL. This may be related to their relatively high MDL values in the method proposed 379 
(10-83 ng/L). Moreover, the consumption figures of these particular substances in Spain 380 
are usually very low [13], resulting in very low concentrations in wastewater.  381 
Among drugs of abuse, benzoylecgonine (196-489 ng/L) was the metabolite 382 
quantified at the highest levels, followed by its precursor cocaine (82-259 ng/L), the 383 
cocaine adulterant levamisole (41-129 ng/L) and the THC metabolites THC-COOH (26-384 
70 ng/L) and THC-OH (19-62 ng/L). These values reflect the pattern of consumption of 385 
illicit drugs in Spain [13], with cocaine and cannabis being the most abused substances 386 
and, therefore, the ones found in higher amounts in wastewater [32]. Other compounds 387 
such as MDMA (2-13 ng/L), methadone (3-13 ng/L) and its metabolite EDDP (<MDL-388 
14 ng/L) were quantified at lower levels. 389 
Benzodiazepine-related compounds were quantified at mean levels <100 ng/L, in 390 
the same order of magnitude than in other European studies [6, 9, 26, 29, 33, 34]. 391 
Lorazepam (44-182 ng/L) and oxazepam (9-100 ng/L) were the most abundant species, 392 
but they were exceeded, in any case, by ritalinic acid (metabolite of methylphenidate, 393 
63-195 ng/L). 394 
Among all the analytes, the highest concentrations were found for the 395 
antidepressant metabolite O-desmethylvenlafaxine (1066-1231 ng/L), followed by its 396 
precursor venlafaxine (459-1063 ng/L). These values are in good agreement with the 397 
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values reported for venlafaxine in the Slovakian city of Trencín (391-947 ng/L) [7], but 398 
they are considerably higher than the levels observed in other Slovakian [7], Greek [6], 399 
German [9] and British [29, 33] cities. Sertraline (176-455 ng/L) and its metabolite 400 
norsertraline (209-531 ng/L) were also quantified at very high concentrations when 401 
compared to other European studies [6, 9, 34, 35], a fact that could be associated to their 402 
desorption from filtered particles in the present work. These substances are highly 403 
retained onto SPM and common sample preparation methodologies (separating aqueous 404 
and solid phases and adding IS after filtration) may underestimate their real levels in 405 
wastewater. However, several factors may affect the occurrence of antidepressants in 406 
sewage from different countries (i.e. different rates of prescription) and any association 407 
with sample preparation/methodological issues may be considered cautiously. 408 
Fluoxetine, norfluoxetine and paroxetine concentrations were in line with or lower than 409 
the concentrations reported in other countries [6, 9, 26, 29, 34-36]. Citalopram (110-183 410 
ng/L), N-desmethylcitalopram (79-136 ng/L) and mirtazapine (27-81 ng/L) had already 411 
been found at similar/higher levels in other cities [6, 9, 34, 36], whereas N-412 
desmethylmirtazapine (14-22 ng/L), duloxetine (17-60 ng/L) and trazodone (35-545 413 
ng/L) are usually not detected or detected at lower concentrations.  414 
Regarding weekly concentrations profiles, and in accordance with the expected 415 
pattern of constant consumption, no clear trend could be observed for any of the 416 
investigated pharmaceuticals, neither for antidepressants nor for benzodiazepines. 417 
Conversely, higher levels were detected for all drugs/related compounds in the weekend 418 
samples (Saturday, Sunday, Monday), reflecting the recreational use of these substances 419 
in the city of Santiago de Compostela.  420 
 421 
4. Conclusions 422 
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A new SPE-UHPLC-MS/MS method has been developed for the multi-residue 423 
determination of 38 psychoactive drugs (covering the most consumed psychoactive 424 
pharmaceuticals and drugs of abuse in Spain) in wastewater. Sample filtration proved to 425 
be a critical step in the loss of the most hydrophobic analytes (methadone, EDDP, THC-426 
COOH, THC-OH and eight antidepressants). This led us to include a washing of the 427 
filters (and its subsequent extraction together with the filtered water) in the final 428 
protocol. This step allowed to reach higher absolute recoveries and lower limits of 429 
detection for these compounds, sometimes not detected, or detected at low –potentially 430 
underestimated– concentrations in real wastewater by other methodologies that simply 431 
extract the filtered aqueous phase (in the best scenario, adding IS before filtration). The 432 
analysis of seven 24 h-composite raw wastewater samples demonstrated the ubiquity of 433 
most of the analytes, with some of the antidepressants quantified at very high levels 434 
when compared to other European studies.  435 
 436 
Appendix A. Supplementary material 437 
 438 
Declarations of interest: none 439 
 440 
Acknowledgements 441 
This work was financially supported by the Spanish Ministry of Economy and 442 
Competitiveness (project no. CTM2014-56628-C3-2-R), the Galician Council of 443 
Culture, Education and Universities (ED431C2017/36 and IGM postdoctoral contract, 444 
Plan Galego I2C-Modalidade B, ED481D 2017/003) and FEDER/ERDF.  445 
 446 
This is the author’s accepted manuscript of González-Mariño et al. J. Chromatogr. A, 1569 (2018) 91-100. © 2018. This 





[1] A.G. Asimakopoulos, K. Kannan, Neuropsychiatric pharmaceuticals and illicit drugs 448 
in wastewater treatment plants: a review, Environ. Chem. 13 (2016) 541-576, 449 
https://doi.org/10.1071/EN15202. 450 
[2] O. Golovko, V. Kumar, G. Fedorova, T. Randak, R. Grabic, Seasonal changes in 451 
antibiotics, antidepressants/psychiatric drugs, antihistamines and lipid regulators in a 452 
wastewater treatment plant, Chemosphere 111 (2014) 418-426, 453 
https://doi.org/10.1016/j.chemosphere.2014.03.132 454 
[3] B. Petrie, R. Barden, B. Kasprzyk-Hordern, A review on emerging contaminants in 455 
wastewaters and the environment: Current knowledge, understudied areas and 456 
recommendations for future monitoring, Water Res. 72 (2015) 3-27, 457 
https://doi.org/10.1016/j.watres.2014.08.053. 458 
[4] B. Subedi, K. Kannan, Occurrence and fate of selected psychoactive 459 
pharmaceuticals and antihypertensives in two wastewater treatment plants in New York 460 
State, USA, Sci. Total Environ. 514 (2015) 273-280, 461 
https://doi.org/10.1016/j.scitotenv.2015.01.098. 462 
[5] D.R. Baker, L. Barron, B. Kasprzyk-Hordern, Illicit and pharmaceutical drug 463 
consumption estimated via wastewater analysis. Part A: Chemical analysis and drug use 464 
estimates, Sci. Total Environ. 487 (2014) 629-641, 465 
https://doi.org/10.1016/j.scitotenv.2013.11.107. 466 
[6] V.L. Borova, N.C. Maragou, P. Gago-Ferrero, C. Pistos, Ν.S. Τhomaidis, Highly 467 
sensitive determination of 68 psychoactive pharmaceuticals, illicit drugs, and related 468 
human metabolites in wastewater by liquid chromatography–tandem mass spectrometry, 469 
Anal. Bioanal. Chem. 406 (2014) 4273-4285, https://doi.org/10.1007/s00216-014-470 
7819-3. 471 
This is the author’s accepted manuscript of González-Mariño et al. J. Chromatogr. A, 1569 (2018) 91-100. © 2018. This 




[7] T. Mackuľak, L. Birošová, M. Gál, I. Bodík, R. Grabic, J. Ryba, J. Škubák, 472 
Wastewater analysis: the mean of the monitoring of frequently prescribed 473 
pharmaceuticals in Slovakia, Environ. Monit. Assess. 188 (2016) 18, 474 
https://doi.org/10.1007/s10661-015-5011-7. 475 
[8] T. Mackuľak, I. Bodík, J. Hasan, R. Grabic, O. Golovko, A. Vojs-Staňová, M. Gál, 476 
M. Naumowicz, J. Tichý, P. Brandeburová, J. Híveš, Dominant psychoactive drugs in 477 
the Central European region: A wastewater study, Forensic Sci. Int. 267 (2016) 42-51, 478 
https://doi.org/10.1016/j.forsciint.2016.08.016. 479 
[9] M.P. Schlüsener, P. Hardenbicker, E. Nilson, M. Schulz, C. Viergutz, T.A. Ternes, 480 
Occurrence of venlafaxine, other antidepressants and selected metabolites in the Rhine 481 
catchment in the face of climate change, Environ. Pollut. 196 (2015) 247-256, 482 
https://doi.org/10.1016/j.envpol.2014.09.019. 483 
[10] Organisation for Economic Co-operation and Development (OECD), Health at a 484 
Glance 2015: OECD Indicators, OECD Publishing, Paris, 2015.  485 
[11] Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Utilización 486 
de medicamentos antidepresivos en España durante el periodo 2000-2013, accessible 487 
through 488 
https://www.aemps.gob.es/medicamentosUsoHumano/observatorio/docs/antidepresivos489 
-2000-2013.pdf, accessed on 16/10/2017. 490 
[12] Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Utilización 491 
de medicamentos ansiolíticos e hipnóticos en España durante el periodo 2000-2012, 492 
accessible through 493 
https://www.aemps.gob.es/medicamentosUsoHumano/observatorio/docs/ansioliticos_hi494 
pnoticos-2000-2012.pdf, accessed on 16/10/2017. 495 
This is the author’s accepted manuscript of González-Mariño et al. J. Chromatogr. A, 1569 (2018) 91-100. © 2018. This 




[13] European Monitoring Centre for Drugs and Drug Addiction, European Drug 496 
Report 2016: Trends and Developments, Publications Office of the European Union, 497 
Luxembourg, 2016. 498 
[14] R. Ma, B. Wang, S. Lu, Y. Zhang, L. Yin, J. Huang, S. Deng, Y. Wang, G. Yu, 499 
Characterization of pharmaceutically active compounds in Dongting Lake, China: 500 
Occurrence, chiral profiling and environmental risk, Sci. Total Environ. 557–558 (2016) 501 
268-275, https://doi.org/10.1016/j.scitotenv.2016.03.053. 502 
[15] P. Verlicchi, M. Al Aukidy, E. Zambello, Occurrence of pharmaceutical 503 
compounds in urban wastewater: Removal, mass load and environmental risk after a 504 
secondary treatment—A review, Sci. Total Environ. 429 (2012) 123-155, 505 
https://doi.org/10.1016/j.scitotenv.2012.04.028. 506 
[16] Y. Hong, V.K. Sharma, P.C. Chiang, H. Kim, Fast-Target Analysis and Hourly 507 
Variation of 60 Pharmaceuticals in Wastewater Using UPLC-High Resolution Mass 508 
Spectrometry, Arch. Environ. Contam. Toxicol. 69 (2015) 525-534, 509 
https://doi.org/10.1007/s00244-015-0214-z. 510 
[17] N.S. Thomaidis, P. Gago-Ferrero, C. Ort, N.C. Maragou, N.A. Alygizakis, V.L. 511 
Borova, M.E. Dasenaki, Reflection of Socioeconomic Changes in Wastewater: Licit and 512 
Illicit Drug Use Patterns, Environ. Sci. Technol. 50 (2016) 10065-10072, 513 
https://doi.org/10.1021/acs.est.6b02417. 514 
[18] D.R. Baker, B. Kasprzyk-Hordern, Multi-residue determination of the sorption of 515 
illicit drugs and pharmaceuticals to wastewater suspended particulate matter using 516 
pressurised liquid extraction, solid phase extraction and liquid chromatography coupled 517 
with tandem mass spectrometry, J. Chromatogr. A, 1218 (2011) 7901-7913, 518 
https://doi.org/10.1016/j.chroma.2011.08.092. 519 
This is the author’s accepted manuscript of González-Mariño et al. J. Chromatogr. A, 1569 (2018) 91-100. © 2018. This 




[19] A. Causanilles, J.A. Baz-Lomba, D.A. Burgard, E. Emke, I. González-Mariño, I. 520 
Krizman-Matasic, A. Li, A.S.C. Löve, A.K. McCall, R. Montes, A.L.N. van Nuijs, C. 521 
Ort, J.B. Quintana, I. Senta, S. Terzic, F. Hernandez, P. de Voogt, L. Bijlsma, 522 
Improving wastewater-based epidemiology to estimate cannabis use: focus on the initial 523 
aspects of the analytical procedure, Anal. Chim. Acta, 988 (2017) 27-33, 524 
https://doi.org/10.1016/j.aca.2017.08.011. 525 
[20] B.F. da Silva, A. Jelic, R. López-Serna, A.A. Mozeto, M. Petrovic, D. Barceló, 526 
Occurrence and distribution of pharmaceuticals in surface water, suspended solids and 527 
sediments of the Ebro river basin, Spain, Chemosphere 85 (2011) 1331-1339, 528 
https://doi.org/10.1016/j.chemosphere.2011.07.051. 529 
[21] J. Tolls, Sorption of Veterinary Pharmaceuticals in Soils:  A Review, Environ. Sci. 530 
Technol. 35 (2001) 3397-3406, https://doi.org/10.1021/es0003021. 531 
[22] R.P. Schwarzenbach, P.M. Gschwend, D.M. Imboden, Environmental Organic 532 
Chemistry, second ed., 2003, ISBN 0-47 1-35750-2. 533 
[23] J.W. Kwon, K.L. Armbrust, Aqueous Solubility, n-Octanol–Water Partition 534 
Coefficient, and Sorption of Five Selective Serotonin Reuptake Inhibitors to Sediments 535 
and Soils, Bull. Environ. Contam. Toxicol. 81 (2008) 128-135, 536 
https://doi.org/10.1007/s00128-008-9401-1. 537 
[24] M. Varga, J. Dobor, A. Helenkár, L. Jurecska, J. Yao, G. Záray, Investigation of 538 
acidic pharmaceuticals in river water and sediment by microwave-assisted extraction 539 
and gas chromatography–mass spectrometry, Microchem. J. 95 (2010) 353-358, 540 
https://doi.org/10.1016/j.microc.2010.02.010. 541 
[25] A.K. McCall, R. Bade, J. Kinyua, F.Y. Lai, P.K. Thai, A. Covaci, L. Bijlsma, 542 
A.L.N. van Nuijs, C. Ort, Critical review on the stability of illicit drugs in sewers and 543 
This is the author’s accepted manuscript of González-Mariño et al. J. Chromatogr. A, 1569 (2018) 91-100. © 2018. This 




wastewater samples, Water Res. 88 (2016) 933-947, 544 
https://doi.org/10.1016/j.watres.2015.10.040.  545 
[26] I. Racamonde, R. Rodil, J.B. Quintana, E. Villaverde-de-Sáa, R. Cela, 546 
Determination of benzodiazepines, related pharmaceuticals and metabolites in water by 547 
solid-phase extraction and liquid-chromatography–tandem mass spectrometry, J. 548 
Chromatogr. A 1352 (2014) 69-79, https://doi.org/10.1016/j.chroma.2014.05.064.  549 
[27] I. González-Mariño, J.B. Quintana, I. Rodríguez, M. Gonzáez-Díez, R. Cela, 550 
Screening and selective quantification of illicit drugs in wastewater by mixed-mode 551 
solid-phase extraction and quadrupole-time-of-flight liquid chromatography-mass 552 
spectrometry, Anal. Chem. 84 (2012) 1708-1717, https://doi.org/10.1021/ac202989e. 553 
[28] I. González-Mariño, J.B. Quintana, I. Rodríguez, N. Sánchez-Méndez, R. Cela, 554 
Transformation of cocaine during water chlorination, Anal. Bioanal.Chem. 404 (2012) 555 
3135-3144, https://doi.org/10.1007/s00216-012-6428-2. 556 
 [29] D.R. Baker, B. Kasprzyk-Hordern, Multi-residue analysis of drugs of abuse in 557 
wastewater and surface water by solid-phase extraction and liquid chromatography-558 
positive electrospray ionisation tandem mass spectrometry, J. Chromatogr. A 1218 559 
(2011) 1620-1631, https://doi.org/10.1016/j.chroma.2011.01.060. 560 
[30] J.A. Baz-Lomba, M.J. Reid, K.V. Thomas, Target and suspect screening of 561 
psychoactive substances in sewage-based samples by UHPLC-QTOF, Anal. Chim. Acta 562 
914 (2016) 81-90, https://doi.org/10.1016/j.aca.2016.01.056. 563 
[31] G. Fedorova, T. Randak, R.H. Lindberg, R. Gabric, Comparison of the quantitative 564 
performance of a Q-Exactive high-resolution mass spectrometer with that of a triple 565 
quadrupole tandem mass spectrometer for the analysis of illicit drugs in wastewater, 566 
Rapid Commun. Mass Spectrom. 27 (2013) 1751-1762, 567 
https://doi.org/10.1002/rcm.6628. 568 
This is the author’s accepted manuscript of González-Mariño et al. J. Chromatogr. A, 1569 (2018) 91-100. © 2018. This 




 [32] C. Ort, A.L.N. van Nuijs, J.D. Berset, L. Bijlsma, S. Castiglioni, A. Covaci, P. de 569 
Voogt, E. Emke, D. Fatta-Kassinos, P. Griffiths, F. Hernández, I. González-Mariño, R. 570 
Grabic, B. Kasprzyk-Hordern, N. Mastroianni, A. Meierjohann, T. Nefau, M. Östman, 571 
Y. Pico, I. Racamonde, M. Reid, J. Slobodnik, S. Terzic, N. Thomaidis, K.V. Thomas, 572 
Spatial differences and temporal changes in illicit drug use in Europe quantified by 573 
wastewater analysis, Addiction 109 (2014) 1338-1352, 574 
https://doi.org/10.1111/add.12570. 575 
 [33] S.E. Evans, P. Davies, A. Lubben, B. Kasprzyk-Hordern, Determination of chiral 576 
pharmaceuticals and illicit drugs in wastewater and sludge using microwave assisted 577 
extraction, solid-phase extraction and chiral liquid chromatography coupled with 578 
tandem mass spectrometry, Anal. Chim. Acta 882 (2015) 112-126, 579 
https://doi.org/10.1016/j.aca.2015.03.039.  580 
[34] L.J.G. Silva, A.M.P.T. Pereira, L.M. Meisel, C.M. Lino, A. Pena, A one-year 581 
follow-up analysis of antidepressants in Portuguese wastewaters: Occurrence and fate, 582 
seasonal influence, and risk assessment, Sci. Total Environ. 490 (2014) 279-287, 583 
https://doi.org/10.1016/j.scitotenv.2014.04.131. 584 
[35] P. Paíga, L.H.M.L.M. Santos, S. Ramos, S. Jorge, J.G. Silva, C. Delerue-Matos, 585 
Presence of pharmaceuticals in the Lis river (Portugal): Sources, fate and seasonal 586 
variation, Sci. Total Environ. 573 (2016) 164-177,  587 
https://doi.org/10.1016/j.scitotenv.2016.08.089. 588 
[36] S.E. Evans, P. Davies, A. Lubben, B. Kasprzyk-Hordern, Determination of chiral 589 
pharmaceuticals and illicit drugs in wastewater and sludge using microwave assisted 590 
extraction, solid-phase extraction and chiral liquid chromatography coupled with 591 
tandem mass spectrometry, Anal. Chim. Acta, 882 (2015) 112-126, 592 
https://doi.org/10.1016/j.aca.2015.03.039. 593 
This is the author’s accepted manuscript of González-Mariño et al. J. Chromatogr. A, 1569 (2018) 91-100. © 2018. This 





This is the author’s accepted manuscript of González-Mariño et al. J. Chromatogr. A, 1569 (2018) 91-100. © 2018. This version is 





Figure 1.  Chromatograms of some representative analytes using a water/MeOH mobile phase 
at pH 2.7 (purple line), pH 7.0 (green line) and pH 10.5 (red line). 
Figure 2. Extracted Ion Chromatogram (EIC) for the first transition (Q1) of all the analytes in 
a 100 ng/mL standard mixture. 
 
Figure 3. Analyte losses (%) during ultrapure water filtration through glass microfiber filters 
(GF), cellulose membranes, hydrophilic nylon and hydrophilic PVDF filters. Error bars 
represent the standard deviation. Numbers above the bars are p-values for ANOVA statistical 
tests assessing the presence/absence of statistically significant differences between the mean 
losses observed with the four types of filters (α = 0.05). 
Figure 4. Analyte losses (%) observed with glass microfiber filters (GF) in ultrapure water 
and in raw wastewater. Error bars represent the standard deviation. Numbers above the bars 
are p-values for Student’s t-tests assessing the presence/absence of statistically significant 






Table 1. Method performance parameters: determination coefficients (R2), relative standard deviations (%RSD), instrumental 
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Alprazolam 0.9982 6.9 2.2 0.4 106 (8) 104 (3) 107 (3) 0.9 1.4 
α-hydroxyalprazolam 0.9961 4.3 1.4 1.1 102 (3) 119 (27) 100 (3) 2.8 4.5 
Diazepam 0.9975 1.5 2.4 0.2 98 (6) 114 (12) 106 (1) 0.5 1.2 
Nordiazepam 0.9973 1.6 1.8 1.7 89 (4) 108 (10) 91 (2) 2.8 3.0 
Oxazepam 0.9984 4.8 1.8 1.1 101 (3) 100 (4) 100 (6) 1.7 8.0 
Temazepam 0.9960 1.5 2.6 0.7 106 (6) 100 (5) 91 (3) 1.7 3.3 
Lorazepam 0.9948 6.1 3.5 0.5 113 (10) 101 (12) 76 (11) 0.9 21 
Lormetazepam 0.9968 1.5 1.8 1.4 71 (10) 99 (3) 99 (12) 3.4 3.7 
Chlordiazepoxide 0.9978 1.4 2.5 1.1 72 (6) 98 (6) 71 (3) 2.3 4.5 
Methylphenidate 0.9985 2.8 2.5 1.0 100 (5) 110 (8) 75 (1) 1.1 1.6 












Citalopram 0.9943 1.5 2.5 0.9 104 (4) 105 (9) 99 (2) 0.9 5.5 
N-desmethylcitalopram 0.9969 3.0 1.4 0.5 104 (1) 103 (9) 107 (3) 1.2 6.3 
Fluoxetine 0.9955 1.8 1.6 0.1 92 (7) 106 (8) 82 (2) 1.0 1.8 
Norfluoxetine 0.9986 2.2 2.7 0.1 106 (5) 110 (9) 94 (12) 0.5 3.3 
Sertraline 0.9981 2.9 3.0 0.3 107 (5) 107 (5) 93 (2) 0.8 4.4 
Norsertraline 0.9948 NA 13 10 132 (9) 92 (16) 114 (2) 10 30 
Venlafaxine 0.9966 3.1 2.9 0.1 104 (4) 104 (7) 98 (3) 0.7 0.9 
O-desmethylvenlafaxine 0.9985 2.4 1.7 0.4 103 (6) 108 (11) 91 (11) 1.1 7.7 
Mirtazapine 0.9976 0.8 2.3 0.1 99 (4) 103 (13) 102 (4) 0.2 1.1 
N-desmethylmirtazapine 0.9928 3.6 3.1 0.1 105 (6) 72 (8) 134 (6) 0.4 6.8 
Duloxetine 0.9987 4.0 3.8 0.1 106 (8) 119 (11) 65 (2) 0.3 8.6 
Paroxetine 0.9953 2.3 1.4 0.4 106 (8) 102 (9) 108 (11) 1.1 6.9 











Amphetamine 0.9932 NA 3.1 6.6 90 (2) 103 (10) 106 (14) 9.0 64 
Methamphetamine 0.9964 2.0 2.9 1.1 89 (5) 103 (9) 102 (2) 1.7 27 
MDMA 0.9971 1.4 2.6 1.1 101 (4) 123 (16) 100 (6) 1.5 1.2 
Cocaine 0.9975 2.0 2.1 0.1 106 (4) 110 (5) 100 (3) 1.1 3.2 
Benzoylecgonine 0.9968 2.0 3.6 0.2 105 (5) 105 (4) 95 (7) 0.3 3.3 
Cocaethylene 0.9977 1.9 2.3 0.1 105 (2) 107 (7) 96 (2) 0.2 0.3 
Levamisole 0.9930 0.8 3.8 0.9 97(6) 92 (9) 79 (2) 1.2 5.8 
THC-OH 0.9985 NA 2.3 7.0 102 (2) 106 (4) 88 (3) 8.2 9.3 
THC-COOH 0.9946 NA 4.0 13 NAc 117 (7) 121 (8) 22 25 
mCPP 0.9967 6.9 2.4 5.0 101 (7) 137 (18) 102 (4) 5.5 82 
Mephedrone 0.9978 1.1 1.8 1.0 106 (4) 101 (10) 114 (3) 1.3 83 
Ketamine 0.9965 0.6 2.3 0.1 105 (7) 103 (9) 116 (3) 0.7 10 
Methadone 0.9971 1.4 2.0 0.2 104 (7) 97 (6) 95 (2) 1.1 1.7 
EDDP 0.9972 3.7 2.6 2.7 87 (6) 98 (11) 79 (3) 3.2 4.8 
 
a Linear range: IQL - 1500 ng/mL for all the analytes excepting sertraline, fluoxetine and lormetazepam (IQL - 500 ng/mL) 
b Repeatability at 5 ng/mL was not calculated for norsertraline, amphetamine, THC-OH and THC-COOH since their IQL > 5 ng/mL 






Table 2. Analyte concentration (mean in ng/L and %RSD in brackets) in 24 h-composite raw wastewater samples collected during one 
week in Santiago de Compostela. <MDL: not detected. <MQL: detected, but below the MQL.  
 



























Alprazolam 5 (24) 2 (28) 4 (11) 6 (29) 3 (12) 3 (5) 4 (29) 
α-hydroxyalprazolam 9 (22) <MQL <MQL 14 (15) 7 (19) 6 (19) 9 (21) 
Diazepam 3 (35) 2 (1) 2 (22) 4 (7) 2 (26) 2 (12) 3 (1) 
Nordiazepam 13 (6) 8 (14) 10 (9) 17 (2) 11 (33) 8 (9) 13 (1) 
Oxazepam 25 (8) 10 (25) 27 (16) 100 (20) 32 (3) 9 (25) 57 (19) 
Temazepam 12 (2) 8 (25) 12 (20) 15 (20) 11 (7) 12 (16) 11 (6) 
Lorazepam 71 (8) 68 (4) 60 (9) 182 (24) 44 (17) 78 (38) 72 (15) 
Lormetazepam 11 (5) 12 (15) 13 (23) 10 (29) 6 (8) 7 (20) 8 (18) 
Chlordiazepoxide 12 (9) 8 (21) 12 (18) 16 (11) 9 (27) 7 (3) 10 (23) 
Methylphenidate 8 (25) 8 (16) 10 (6) 13 (19) 11 (8) 6 (11) 8 (12) 












Citalopram 140 (4) 119 (11) 161 (2) 110 (5) 123 (5) 129 (7) 183 (4) 
N-desmethylcitalopram 136 (3) 79 (16) 113 (3) 92 (10) 79 (12) 88 (9) 110 (4) 
 Fluoxetine 38 (13) 29 (4) 49 (9) 23 (8) 36 (1) 36 (6) 64 (7) 
Norfluoxetine 32 (29) 16 (12) 32 (3) 19 (6) 23 (8) 26 (29) 43 (5) 
Sertraline 258 (7) 227 (3) 396 (2) 176 (5) 254 (9) 232 (8) 455 (4) 
Norsertraline 233 (4) 230 (17) 471 (13) 209 (9) 309 (24) 256 (9) 531 (31) 
Venlafaxine 551 (6) 459 (2) 1063 (6) 661 (1) 466 (3) 478 (1) 549 (1) 
O-desmethylvenlafaxine 1231 (5) 1102 (15) 1066 (13) 1124 (6) 1152 (5) 1175 (2) 1213 (6) 
Mirtazapine 81 (8) 31 (16) 33 (7) 27 (3) 30 (2) 33 (13) 36 (19) 
N-desmethylmirtazapine 20 (11) 17 (7) 21 (8) 14 (14) 16 (13) 16 (26) 22 (19) 
Duloxetine 60 (22) 21 (8) 45 (18) 17 (19) 23 (6) 24 (16) 46 (21) 
Paroxetine 24 (10) 21 (10) 26 (8) 13 (8) 18 (10) 17 (1) 35 (8) 











Amphetamine <MDL <MDL <MDL <MDL <MDL <MDL <MDL 
Methamphetamine <MDL <MDL <MDL <MDL <MDL <MDL <MDL 
MDMA 6 (6) 2 (26) 2 (6) 6 (13) 8 (11) 11 (12) 13 (10) 
Cocaine 169 (25) 82 (24) 165 (1) 230 (5) 215 (1) 259 (4) 240 (9) 
Benzoylecgonine 398 (6) 196 (31) 289 (11) 331 (7) 371 (9) 464 (3) 489 (24) 
Cocaethylene 4 (11) 1 (36) 4 (9) 7 (3) 7 (11) 11 (11) 13 (5) 
Levamisole 69 (15) 41 (16) 47 (4) 63 (2) 76 (14) 129 (23) 129 (23) 
THC-OH 58 (14) 31 (23) 19 (8) 54 (12) 34 (18) 28 (6) 62 (11) 
THC-COOH 53 (18) 26 (4) 33 (20) 70 (9) 29 (4) 47 (18) 56 (8) 
mCPP <MDL <MDL <MDL <MDL <MDL <MDL <MDL 
Mephedrone <MDL <MDL <MDL <MDL <MDL <MDL <MDL 
Ketamine <MDL <MDL <MDL <MDL <MDL <MDL <MDL 
Methadone 8 (30) 3 (19) 6 (34) 13 (10) 4 (13) 4 (24) 7 (1) 
EDDP 12 (16) <MDL <MQL 14 (12) <MDL 5 (9) 10 (16) 
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Formic Acid 0.1% Ammonium acetate 5 mM Ammonia 5 mM
Figure 1
Figure 2
Calibrado con IS 50 ppb
Time




160512_17_CAL_100ppb_a 48: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
Time




160512_17_CAL_100ppb_a 61: MRM of 2 Channels ES+ 





Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 28: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 22: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 30: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 41: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 59: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 71: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 14: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
Time




160512_17_CAL_100ppb_a 40: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 12: MRM of 5 Channels ES+ 





Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 52: MRM of 2 Channels ES+ 





Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 63: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 50: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 37: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 45: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 34: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 24: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 19: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 20: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 18: MRM of 2 Channels ES+ 





Calibrado con IS 50 ppb
Time




160512_17_CAL_100ppb_a 38: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 65: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 75: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 1: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 3: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 7: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
Time




160512_17_CAL_100ppb_a 44: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 32: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 58: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 10: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 69: MRM of 3 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 73: MRM of 3 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 8: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 5: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
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160512_17_CAL_100ppb_a 15: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
Time




160512_17_CAL_100ppb_a 51: MRM of 2 Channels ES+ 




Calibrado con IS 50 ppb
Time




160512_17_CAL_100ppb_a 25: MRM of 2 Channels ES+ 
















































































Appendix A. Supplementary material to: 
 
Multi-residue determination of psychoactive pharmaceuticals, illicit 
drugs and related metabolites in wastewater by Ultra-High Performance 
Liquid Chromatography-Tandem Mass Spectrometry 
Iria González-Mariño*, Verónica Castro, Rosa Montes, Rosario Rodil, Ana Lores, Rafael Cela, 
José Benito Quintana 
Department of Analytical Chemistry, Nutrition and Food Sciences, IIAA – Institute for Food 
Analysis and Research, Universidade de Santiago de Compostela, Constantino Candeira S/N, 
15782 – Santiago de Compostela, Spain. 
 
*Corresponding author:  
Iria González Mariño 
phone: +34 881 816035 





Table S1.  Analytes, labeled compounds used as IS, retention time (RT), cone voltage (CV), quantifier (Q1) and qualifier (Q2) m/z transition (precursor > 
product ion), and collision energy (CE) selected in every case.  



























Alprazolam Alprazolam-D5 2.7 60 309>205 46 309>281 34 
α-hydroxyalprazolam α-hydroxyalprazolam-D5 2.5 64 325>297 24 325>216 38 
Diazepam Diazepam-D5 3.7 60 285>193 32 285>89 62 
Nordiazepam Nordiazepam-D5 3.3 60 271>140 30 271>165 30 
Oxazepam Oxazepam-D5 2.6 38 287>241 22 287>269 14 
Temazepam Temazepam-D5 3.0 42 301>255 20 301>283 14 
Lorazepam Lorazepam-D4 2.7 45 321>275 20 321>303 14 
Lormetazepam Alprazolam-D5 3.2 40 335>289 22 335>317 14 
Chlordiazepoxide Alprazolam-D5 3.2 34 300>283 14 300>227 24 
Methylphenidate Methylphenidate-D9 3.5 6 234>84 20 234>91 40 












Citalopram Citalopram-D6 4.7 50 325>109 30 325>262 22 
N-desmethylcitalopram N-desmethylcitalopram-D3 4.8 44 311>109 26 311>262 16 
Fluoxetine Fluoxetine-D6 5.0 26 310>44 14 310>148 8 
Norfluoxetine Norfluoxetine-D6 5.0 18 296>134 8 296>30 10 
Sertraline Sertraline-D3 5.0 24 306>159 24 306>275 12 
Norsertraline Norsertraline-13C6 5.0 14 292>159 20 292>275 8 
Venlafaxine Venlafaxine-D6 4.8 38 278>58 20 278>260 12 
O-desmethylvenlafaxine O-desmethylvenlafaxine-D6 2.9 32 264>58 18 264>246 12 
Mirtazapine Trazodone-D6 4.1 46 266>195 28 266>72 24 
N-desmethylmirtazapine Cocaine-D3 2.9 46 252>195 24 252>209 24 
Duloxetine Duloxetine-D3 5.0 16 298>154 6 298>44 46 
Paroxetine Paroxetine-D6 4.9 48 330>70 30 330>44 22 
3 
 
  Analyte IS RT (min) CV (V) Q1 CE (V) Q2 CE (V) 








Amphetamine Amphetamine-D6 2.2 24 136>91 16 136>119 10 
Methamphetamine Methamphetamine-D5 3.1 28 150>91 16 150>119 10 
MDMA MDMA-D5 2.9 28 194>163 12 194>105 26 
Cocaine Cocaine-D3 3.8 30 304>182 22 304>82 32 
Benzoylecgonine Benzoylecgonine-D3 0.5 44 290>168 20 290>105 32 
Cocaethylene Cocaethylene-D3 4.5 32 318>196 22 318>82 32 
Levamisole Cocaine-D3 1.7 48 205>178 22 205>91 36 
THC-OH THC-OH-D3 5.0 32 331>313 14 331>193 26 
THC-COOH THC-COOH-D3 2.2 46 345>327 18 345>299 22 
mCPP mCPP-D8 2.4 44 197>154 18 197>44 22 
Mephedrone Mephedrone-D3 2.1 30 178>160 12 178>145 20 
Ketamine Ketamine-D4 2.7 36 238>125 24 238>207 16 
Methadone Methadone-D3 5.1 50 310>105 32 310>265 16 












Alprazolam-D5 - 2.7 60 314>286 34 - - 
α-hydroxyalprazolam-D5 - 2.5 64 330>302 24 - - 
Diazepam-D5 - 3.7 60 290>198 32 - - 
Nordiazepam-D5 - 3.3 60 276>140 30 - - 
Oxazepam-D5 - 2.6 38 292>246 22 - - 
Temazepam-D5 - 3.0 42 306>260 20 - - 
Lorazepam-D4 - 2.7 45 325>279 20 - - 
Methylphenidate-D9 - 3.5 6 243>93 20 - - 
Ritalinic Acid-D10 - 0.4 22 230>93 20 - - 
Citalopram-D6 - 4.7 50 331>109 30 - - 
N-desmethylcitalopram-D3 - 4.8 44 314>109 26 - - 
Fluoxetine-D6 - 5.0 26 316>44 14 - - 
4 
 
  Analyte IS RT (min) CV (V) Q1 CE (V) Q2 CE (V) 
Norfluoxetine-D6 - 5.0 18 302>30 10 - - 
Sertraline-D3 - 5.0 24 309>275 12 - - 
Norsertraline-13C6 - 5.0 14 298>159 20 - - 
Venlafaxine-D6 - 4.8 38 284>64 20 - - 
O-desmethylvenlafaxine-D6 - 2.9 32 270>64 18 - - 
Duloxetine-D3 - 5.0 16 301>157 6 - - 
Paroxetine-D6 - 4.9 48 336>74 30 - - 
Trazodone-D6 - 4.2 52 378>150 38 - - 
Amphetamine-D6 - 2.2 24 142>125 10 - - 
Methamphetamine-D5 - 3.1 28 155>92 16 - - 
MDMA-D5 - 2.9 28 199>165 12 - - 
Cocaine-D3 - 3.8 30 307>185 22 - - 
Benzoylecgonine-D3 - 0.5 44 293>171 20 - - 
Cocaethylene-D3 - 4.5 32 321>199 22 - - 
THC-OH-D3 - 5.0 32 334>316 14 - - 
THC-COOH-D3 - 2.2 46 348>46 40 - - 
mCPP-D8 - 2.4 44 205>158 18 - - 
Mephedrone-D3 - 2.1 30 181>148 20 - - 
Ketamine-D4 - 2.7 36 242>129 24 - - 
Methadone-D3 - 5.1 50 313>105 32 - - 
EDDP-D3 - 5.3 28 281>234 34 - - 
5 
 
Table S2.  Comparison of the performance of the proposed method with that of other multi-residue analytical methods for the determination of 
psychoactive substances in wastewater. Abbreviations: percentage of recovery (%R); method quantification limit (MQL); Glass fiber (GF); 
Polytetrafluoroethylene (PTFE); Triple quadrupole (QqQ); Quadrupole-time-of-flight (QTOF); Multiple reaction monitoring (MRM); Product ion scan (PIS); 
Internal standards (IS); Methanol (MeOH); Acetonitrile (ACN); Acetic acid (AA); Formic acid (FA); Positive ionization (PI); Negative ionization (NI). 
Analytes 





Pretreatment Extraction LC-MS Run time 
              
65 stimulants, including illicit 
drugs, benzodiazepines, 
antidepressants and selected 
metabolites 
100 mL of sample 
Filtration through GF 2.7 
µm filters + GF 0.7 µm 
filters 
Acidification to pH 1.8-1.9 
Addition of IS 
SPE on Oasis MCX 60 
mg 
Filtration of the 
extract through 0.2 
µm PTFE filters 
UPLC-(ESI+)-MS/MS on QqQ (MRM) 
Acquity UPLC BEH C18 column (150 
× 1 mm, 1.7 µm) 
Mobile phase: 0.3% AA in 
water:MeOH 80:20 and 0.3% AA in 
MeOH 
34 min 
 (IS corrected 
%R) 
39-226% 
> 60% for most 
analytes 
0.5-140 [30] 
              
68 psychoactive substances, 
including illicit drugs, 
benzodiazepines, 
antidepressants and selected 
metabolites 
50 mL of sample 
Filtration through GF 0.7 
µm filters 
Acidification to pH 2.5 
Addition of IS 
SPE on Strata XC 200 
mg 
Filtration of the 
extract through 0.2 
µm RC filters 
UPLC-(ESI+ and ESI-)-MS/MS on 
QqQ (MRM) 
Kinetex PFP column (50 × 2.1 mm, 
1.7 µm) 
Mobile phase: 0.05% FA in water 
and 0.05% FA in MeOH 





80-120% for > 
80% analytes 
0.3-558 [6] 





metabolites and related 
pharmaceuticals 
100 mL of sample 
Addition of IS 
Filtration through GF 0.7 
µm filters + membrane 
0.45 µm filters 
SPE on Oasis MCX 60 
mg 
HPLC-(ESI+)-MS/MS on QqQ (MRM) 
Synergi Fusion column (100 × 2.0 
mm, 4 µm) 
Mobile phase: 0.1% AA in water and 








              
51 psychoactive substances 
including illicit drugs, 
benzodiazepines, 
antidepressants and selected 
metabolites 
100 mL of sample 
Addition of IS 
Auto SPE-DEX 
HLB discs (47 mm i.d.) 
UPLC-(ESI+)-MS on QTOF (MSe) 
Acquity UPLC HSS C18 column (150 
× 2.1 mm, 1.8 µm) 
Mobile phase: 5 mM Ammonium 





> 60% for most 
analytes 
0.4-187 [31] 




illicit drugs, benzodiazepines, 
antidepressants and selected 
metabolites 
1 mL of sample 
Addition of IS 
Filtration through 
cellulose 0.45 µm syringe 
filters 
In-line SPE 
Hyperil Gold (20 × 2.1, 
12 µm) 
HPLC-(ESI+)-MS/MS on QqQ (MRM) 
HPLC-MS on Q-Orbitrap (Full Scan 
and Product Ion Scan) 
Cogen bidentate column (50 × 2.1 
mm, 3 µm) 



















antidepressants and selected 
metabolites 
100 mL of sample 
Centrifugation 
Filtration through GF 1 
µm filter 
Addition of IS 
SPE on Oasis HLB 200 
mg 
HPLC-(ESI+)-MS/MS on QqQ (MRM) 
Hypersil Gold column (150 × 2.1 
mm, 3 µm) 
Mobile phase: 0.1% FA in water and 






      
  
38 psychoactive substances 
including illicit drugs, 
benzodiazepines, 
antidepressants and selected 
metabolites 
100 mL of sample 
Addition of IS 
Filtration through GF 0.7 
µm filter 
Wash of the filters with 2 
× 5 mL MeOH 
SPE on Oasis MCX 150 
mg 
UPLC-(ESI+)-MS/MS on QqQ (MRM) 
Kinetex EVO C18 column (50 × 2.1, 
1.7 µm) 
Mobile phase: 5 mM NH3 in water 

















estudo volumes 5 micro
Time




















160310_mix250ppb_5micro 7: MRM of 5 Channels ES+ 
220 > 84 (Ácido ritalínico)
1.01e7
0.44
160310_mix250ppb_4micro 7: MRM of 5 Channels ES+ 
220 > 84 (Ácido ritalínico)
9.37e6
0.44
160310_mix250ppb_3micro 7: MRM of 5 Channels ES+ 
220 > 84 (Ácido ritalínico)
8.75e6
0.43
160310_mix250ppb_2micro 7: MRM of 5 Channels ES+ 
220 > 84 (Ácido ritalínico)
8.36e6
0.43
160310_mix250ppb_1micro 7: MRM of 5 Channels ES+ 









estudo volumes 3 micro
Time




















160310_mix250ppb_5micro 19: MRM of 2 Channels ES+ 
290 > 168 (Benzoilecgoine)
9.15e6
0.46
160310_mix250ppb_4micro 19: MRM of 2 Channels ES+ 
290 > 168 (Benzoilecgoine)
8.72e6
0.46
160310_mix250ppb_3micro 19: MRM of 2 Channels ES+ 
290 > 168 (Benzoilecgoine)
8.07e6
0.45
160310_mix250ppb_2micro 19: MRM of 2 Channels ES+ 
290 > 168 (Benzoilecgoine)
7.87e6
0.45
160310_mix250ppb_1micro 19: MRM of 2 Channels ES+ 









estudo volumes 4 micro
Time




















160310_mix250ppb_5micro 41: MRM of 2 Channels ES+ 
372 > 148 (Trazodone)
2.34e7
4.26
160310_mix250ppb_4micro 41: MRM of 2 Channels ES+ 
372 > 148 (Trazodone)
1.95e7
4.26
160310_mix250ppb_3micro 41: MRM of 2 Channels ES+ 
372 > 148 (Trazodone)
1.51e7
4.26
160310_mix250ppb_2micro 41: MRM of 2 Channels ES+ 
372 > 148 (Trazodone)
1.04e7
4.26
160310_mix250ppb_1micro 41: MRM of 2 Channels ES+ 











Figure S2. Analyte recovery (%, relative to analyte response when spiked after filtration) in 
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